All filters
Slidesets
A meta-analysis on repeatability of magnetic resonance elastography of liver- Suraj Serai
Presented at:
International Workshop on NASH Biomarkers 2017
Slidesets
Transient elastography & other techniques- Raj Vuppalanchi, MBBS
Presented at:
International Workshop on NASH Biomarkers 2017
Slidesets
Breath tests- Shadab Siddiqui, MD
Presented at:
International Workshop on NASH Biomarkers 2017
Slidesets
Principles of kinetic measures- Greg Everson, MD, FACP
Presented at:
International Workshop on NASH Biomarkers 2017
Slidesets
Novel multiparametric magnetic resonance elastography (MRE) protocol accurately predicts NAS score for NASH diagnosis- Alina Allen
Presented at:
International Workshop on NASH Biomarkers 2017
Slidesets
Big data vs. the individual liver - regulatory perspective- Robert Schuck, PharmD, PhD
Presented at:
International Workshop on NASH Biomarkers 2017
Slidesets
Serum GP73 as a surrogate biomarker of significant liver fibrosis and cirrhosis in NAFLD- Fengmin Lu
Presented at:
International Workshop on NASH Biomarkers 2017
Slidesets
Future scenarios of algorithm building- Tom Travison, PhD
Presented at:
International Workshop on NASH Biomarkers 2017
Slidesets
A precision medicine approach to comprehensive NAFLD diagnosis via metabolomics-based liquid biopsy- Pablo Ortiz
Presented at:
International Workshop on NASH Biomarkers 2017
Slidesets
Next-Generation Sequencing (NGS) of two independent cohorts identifies eleven circulating miRNAs for diagnosis of NASH and fibrosis- Sven Francque
Presented at:
International Workshop on NASH Biomarkers 2017
Slidesets
Navigating NASH biomarkers: From discovery to clinical practice- John Sninsky, PhD
Presented at:
International Workshop on NASH Biomarkers 2017
Slidesets
Integrated assessment of diabetes, cardiovascular and liver risks and its potential application in the clinical management of NAFLD- Arun Sanyal, MD, MBBS
Presented at:
International Workshop on NASH Biomarkers 2017
Slidesets
Can Bariatric surgery convert a non-candidate to a candidate? - Julie Heimbachx, MD
Presented at:
Symposium on Key Issues in Liver Transplantation for NASH 2016
Slidesets
What is an acceptable BMI - Lee Kaplan, MD, PhD
Presented at:
Symposium on Key Issues in Liver Transplantation for NASH 2016
Slidesets
How should we optimize immunosuppression? - Kittie Wynne, MD, PhD
Presented at:
Symposium on Key Issues in Liver Transplantation for NASH 2016
Slidesets
Rifampin vs. Rifapentine: a debate over the preferred rifamycin | Kelly Dooley, MD, PhD
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2016
Slidesets
Pharmacokinetic Modeling and Simulation of the Interaction between Moxifloxacin and Rifapentine in Healthy Volunteers | M. Imperial
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2016
Slidesets
Lung Tissue Concentrations of Pyrazinamide among Patients with Tuberculosis | R. Kempker
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2016
Slidesets
Early interventions for diabetes related tuberculosis hasten sputum microbiological clearance in Virginia, USA | S. Heysell
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2016
Slidesets
Sub-therapeutic concentrations of anti-tuberculosis drugs in children when treated according to indian dosing recommendation | B. Guiastrennec
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2016
Slidesets
A Need for altering Tuberculosis Dosing Regiments for patients with HIV-associated Tuberculous Meningitis | G. Aljayyoussi
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2016
Slidesets
Lost in translation: learning from preclinical data | Gerry Davies
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2016